Breaking News Instant updates and real-time market news.

LMCA

Liberty Media

$0.00

(0.00%)

, IHRT

iHeartMedia

$0.00

(0.00%)

06:41
07/10/18
07/10
06:41
07/10/18
06:41

Liberty Media continues to express interest in iHeartMedia, WSJ reports

Liberty Media Corp. (LMCA) has continued to express interest in bankrupt iHeartMedia (IHRT), despite officially abandoning a plan to purchase a stake in the radio broadcaster last month, potentially setting up a bidding battle with private equity firm Silver Lake, the Wall Street Journal reports, citing people familiar with the matter. Liberty, which owns a controlling interest in Sirius XM (SIRI), is working to revamp its initial offer of roughly $1.2B for a 40% stake, which comes as Silver Lake has made a bid to purchase 20% of iHeart. Reference Link

LMCA

Liberty Media

$0.00

(0.00%)

IHRT

iHeartMedia

$0.00

(0.00%)

SIRI

Sirius XM

$7.04

0.035 (0.50%)

  • 13

    Aug

  • 14

    Aug

LMCA Liberty Media
$0.00

(0.00%)

10/19/17
FBNS
10/19/17
NO CHANGE
FBNS
FBN wonders if Liberty Media should buy rest of Live Nation
Liberty Media (LMCA) currently owns 69.6M shares of Live Nation Entertainment (LYV), or 34.4% of the outstanding shares, FBN Securities analyst Robert Routh tells investors in a research note. The stake cannot go above 35% without approval from the Live Nation board or if Liberty tenders for all the equity it does already own, the analyst points out. Liberty Media tracks its stake via Liberty Formula One Group (FWONA). Routh notes. Liberty Media's restriction on Live Nation is the same one that was in place with HSN, Inc. (HSNI), which QVC Group (QVCA) recently agreed to purchase in its entirety. The analyst wonders if it makes sense for Liberty, given where Formula One is trading, to attempt to tender for the rest of Live Nation now, using equity as the deal currency. Such a move would not only put 100% of Live Nation under the Liberty Media umbrella, it would also make it easy for Liberty to highlight the value of Formula 1, Live Nation or both without any "onerous" tax consequences, Routh contends. Shares of Live Nation are up 17c to $42.76 in midday trading.
07/03/18
IMPC
07/03/18
NO CHANGE
Target $32
IMPC
Outperform
Discovery will not bid for Fox regional sports networks, says Imperial Capital
Imperial Capital analyst David Miller says Discovery (DISCA) is seeing "unnecessary selling pressure" on media reports that the company is a potential bidder for the Fox regional sports networks, which Disney (DIS), through its pending acquisition of the entertainment assets of 21st Century Fox (FOXA), will have to divest, as per the Department of Justice decree. The analyst believes potential bidders for these assets will include Charter (CHTR), Liberty Media (LMCA), Altice (ATUS), and various private equity entities, but not Discovery. Discovery is fully occupied with the integration of Scripps Networks, the sale of its headquarters building in Bethesda, Maryland, as well as ratings issues at its core Discovery Channel, Miller tells investors in a research note. Further, he notes that Discovery already pledged $2B in additional sports rights to broadcast various PGA Tour events via its networks outside of the U.S. through 2030. As such, the analyst thinks the recent pullback has created an "attractive opportunity to either establish new positions, or for existing holders to lower their bases." Miller keeps an Outperform rating on Discovery with a $32 price target.
IHRT iHeartMedia
$0.00

(0.00%)

06/26/18
LEHM
06/26/18
DOWNGRADE
Target $43
LEHM
Equal Weight
Liberty SiriusXM downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Kannan Venkateshwar downgraded Liberty SiriusXM (LSXMA) to Equal Weight from Overweight and cut his price target to $43 from $50, telling investors in a research note that while he has recommended the stock over SiriusXM (SIRI), which was downgraded this morning to Underweight from Equal Weight, given the changing story in SiriusXM equity and its valuation, the current ~30% NAV discount may close due to SiruxXM coming down rather than Liberty SiriusXM going up. The analyst said it is "not surprising" Liberty has been looking at other uses of cash such as iHeart (IHRT) instead of buying more stock.
SIRI Sirius XM
$7.04

0.035 (0.50%)

06/28/18
JPMS
06/28/18
NO CHANGE
Target $6
JPMS
Underweight
JPMorgan views potential SiriusXM, Live Nation deal as unlikely
JPMorgan analyst Sebastiano Petti raised his price target for SiriusXM Radio to $6 from $5 while maintaining an Underweight rating on the shares. The analyst continues to view the valuation as full amid his expectations for slower growth in the years ahead as the business matures. Moderating subscriber gains and a more competitive steaming music landscape have led SiriusXM to explore investments in adjacent platforms in order to fuel additional growth, Petti tells investors in a research note. The analyst, however, does not see the industrial logic of potentially combining SiriusXM with Live Nation (LYV), something he notes that parent Liberty Media has suggested in the past. Petti sees a near-term deal as unlikely and also does not see SiriusXM as a potential takeover target.
06/29/18
BRRR
06/29/18
UPGRADE
BRRR
Outperform
SiriusXM upgraded to Outperform from Market Perform at Barrington
06/29/18
BRRR
06/29/18
UPGRADE
Target $8
BRRR
Outperform
Barrington upgrades Sirius XM to Outperform following recent pullback
Barrington analyst James Goss upgraded Sirius XM Holdings to Outperform from Market Perform with an $8 price target. The stock closed yesterday up 17c to $6.82. The analyst remains impressed with the longer-term story Sirius continues to offer and considers the recent downward move in the stock price as providing a buying opportunity. With the stock down about 12% from the recent peak, it seems reasonable to now restore an Outperform rating, Goss tells investors in a research note.
06/29/18
06/29/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. KB Home (KBH) upgraded to Buy from Underperform at BofA/Merrill with analyst John Lovallo saying KB Home's execution, margins and returns have exceeded his expectations for numerous quarters and expects solid homebuilding growth through 2020. 2. Sirius XM (SIRI) upgraded to Outperform from Market Perform at Barrington with analyst James Goss stating he is impressed with the longer-term story Sirius continues to offer and considers the recent downward move in the stock price as providing a buying opportunity. 3. Matador (MTDR) upgraded to Buy from Hold at KLR Group with analyst Gail Nicholson saying the company offers investors "solid" execution, a "strong" balance sheet and numerous catalysts which could unlock incremental value. 4. Duluth Holdings (DLTH) upgraded to Outperform from Market Perform at William Blair with analyst Dylan Carden stating he has greater conference that the direct channel will stabilize and even likely accelerate as new retail markets enter their second year. 5. American Express (AXP) upgraded to Buy from Neutral at Buckingham with analyst Chris Brendler citing the DOJ case being resolved and evidence of "compelling momentum" across its platform. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

APOP

Cellect Biotechnology

$5.29

0.04 (0.76%)

08:28
10/22/18
10/22
08:28
10/22/18
08:28
Hot Stocks
Cellect Biotechnology reports technological breakthrough in Apotainer production »

Cellect Biotechnology has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:27
10/22/18
10/22
08:27
10/22/18
08:27
Conference/Events
Cowen Internet & new media analyst to hold an analyst/industry conference call »

Internet & New Media…

HOG

Harley-Davidson

$39.56

-0.81 (-2.01%)

08:26
10/22/18
10/22
08:26
10/22/18
08:26
Recommendations
Harley-Davidson analyst commentary  »

Harley-Davidson downside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

AGLE

Aeglea BioTherapeutics

$9.32

-0.58 (-5.86%)

08:25
10/22/18
10/22
08:25
10/22/18
08:25
Hot Stocks
Aeglea BioTherapeutics presents clinical data on pegzilarginase at ESMO »

Aeglea BioTherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTMX

CytomX Therapeutics

$15.43

-1.075 (-6.52%)

08:25
10/22/18
10/22
08:25
10/22/18
08:25
Conference/Events
CytomX Therapeutics to host conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

CFG

Citizens Financial

$36.36

1.44 (4.12%)

08:24
10/22/18
10/22
08:24
10/22/18
08:24
Upgrade
Citizens Financial rating change  »

Citizens Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCI

HCI Group

$43.21

-0.35 (-0.80%)

08:23
10/22/18
10/22
08:23
10/22/18
08:23
Hot Stocks
HCI Group estimates $6M-$18M in losses from Hurricane Michael »

HCI Group has issued an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

GHDX

Genomic Health

$64.39

-3.59 (-5.28%)

08:23
10/22/18
10/22
08:23
10/22/18
08:23
Hot Stocks
Genomic Health reports results from multiple studies of Oncotype cancer tests »

Genomic Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$158.35

2.15 (1.38%)

, AKAM

Akamai

$64.27

-0.19 (-0.29%)

08:21
10/22/18
10/22
08:21
10/22/18
08:21
Conference/Events
Money 20/20 to hold a conference »

U.S.A. Money 20/20 will…

ACN

Accenture

$158.35

2.15 (1.38%)

AKAM

Akamai

$64.27

-0.19 (-0.29%)

T

AT&T

$32.86

0.36 (1.11%)

COF

Capital One

$91.67

1.32 (1.46%)

CSCO

Cisco

$45.32

-0.15 (-0.33%)

C

Citi

$68.83

0.21 (0.31%)

CTSH

Cognizant

$73.69

0.09 (0.12%)

CS

Credit Suisse

$13.14

-0.025 (-0.19%)

DBD

Diebold

$4.12

0.16 (4.04%)

DFS

Discover

$76.07

1.085 (1.45%)

GOOG

Alphabet

$1,096.41

8.51 (0.78%)

IBM

IBM

$129.16

-1.36 (-1.04%)

INFY

Infosys

$9.58

0.04 (0.42%)

JPM

JPMorgan

$107.92

-0.21 (-0.19%)

LC

LendingClub

$3.63

0.04 (1.11%)

MA

MasterCard

$203.12

-0.69 (-0.34%)

MSFT

Microsoft

$108.55

0.01 (0.01%)

MCO

Moody's

$159.91

1.79 (1.13%)

MC

Moelis

$50.87

-0.63 (-1.22%)

V

Visa

$140.06

0.74 (0.53%)

WFC

Wells Fargo

$52.88

-0.225 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 16

    Nov

  • 26

    Nov

  • 28

    Nov

  • 14

    Jan

  • 29

    Jan

  • 26

    Feb

  • 03

    Mar

  • 12

    Apr

  • 15

    Apr

  • 13

    Jul

  • 13

    Jul

  • 12

    Oct

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:21
10/22/18
10/22
08:21
10/22/18
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMED

OncoMed

$2.47

-0.17 (-6.44%)

08:20
10/22/18
10/22
08:20
10/22/18
08:20
Hot Stocks
OncoMed presents interim results for navicixizumab with paclitaxel at ESMO »

OncoMed announced interim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
10/22/18
10/22
08:20
10/22/18
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCO

Taubman Centers

$54.20

0.29 (0.54%)

08:20
10/22/18
10/22
08:20
10/22/18
08:20
Upgrade
Taubman Centers rating change  »

Taubman Centers upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 05

    Nov

  • 07

    Nov

ACN

Accenture

$158.35

2.15 (1.38%)

, ADP

ADP

$143.31

0.36 (0.25%)

08:20
10/22/18
10/22
08:20
10/22/18
08:20
Conference/Events
Oracle to hold a conference »

Oracle OpenWorld…

ACN

Accenture

$158.35

2.15 (1.38%)

ADP

ADP

$143.31

0.36 (0.25%)

ATTU

Attunity

$15.81

-0.35 (-2.17%)

CTSH

Cognizant

$73.69

0.09 (0.12%)

DLR

Digital Realty

$112.62

0.86 (0.77%)

DXC

DXC Technology

$88.28

-0.08 (-0.09%)

KRO

Kronos Worldwide

$14.96

0.15 (1.01%)

INTC

Intel

$43.98

-1 (-2.22%)

IBM

IBM

$129.16

-1.36 (-1.04%)

G

Genpact

$28.76

-0.1 (-0.35%)

FEYE

FireEye

$16.98

-0.71 (-4.01%)

NTNX

Nutanix

$38.76

-2.21 (-5.39%)

PRFT

Perficient

$25.71

-0.39 (-1.49%)

SAP

SAP

$109.02

1.93 (1.80%)

TECD

Tech Data

$69.70

-1.61 (-2.26%)

TRI

Thomson Reuters

$46.61

-0.26 (-0.55%)

VMW

VMware

$140.57

-4.94 (-3.40%)

ORCL

Oracle

$47.59

0.19 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 16

    Nov

  • 06

    Dec

  • 10

    Dec

  • 03

    Mar

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
10/22/18
10/22
08:20
10/22/18
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$187.83

0.79 (0.42%)

08:20
10/22/18
10/22
08:20
10/22/18
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$70.00

-0.04 (-0.06%)

08:19
10/22/18
10/22
08:19
10/22/18
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$71.50

-0.67 (-0.93%)

08:19
10/22/18
10/22
08:19
10/22/18
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$54.31

-1.7 (-3.04%)

, BIIB

Biogen

$319.85

-10.4 (-3.15%)

08:19
10/22/18
10/22
08:19
10/22/18
08:19
Conference/Events
CBI-Division of UBM Americas to hold a conference »

8th Annual IRT 2018 will…

BMY

Bristol-Myers

$54.31

-1.7 (-3.04%)

BIIB

Biogen

$319.85

-10.4 (-3.15%)

PFE

Pfizer

$44.50

0.48 (1.09%)

AMGN

Amgen

$201.75

-1.03 (-0.51%)

VRTX

Vertex

$175.79

-3.21 (-1.79%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ADXS

Advaxis

$0.65

-0.0354 (-5.17%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

ICPT

Intercept

$95.73

-3.67 (-3.69%)

ORCL

Oracle

$47.59

0.19 (0.40%)

INCY

Incyte

$66.09

1.66 (2.58%)

SHPG

Shire

$175.16

-1.74 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 30

    Oct

  • 07

    Nov

  • 09

    Nov

  • 14

    Nov

  • 21

    Dec

  • 20

    May

XLY

Consumer Discretionary Sector SPDR

$106.34

-1.06 (-0.99%)

08:19
10/22/18
10/22
08:19
10/22/18
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$13.19

0.005 (0.04%)

08:19
10/22/18
10/22
08:19
10/22/18
08:19
Downgrade
Barrick Gold rating change  »

Barrick Gold downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$53.13

-0.36 (-0.67%)

08:19
10/22/18
10/22
08:19
10/22/18
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOLD

Randgold

$81.91

0.23 (0.28%)

08:19
10/22/18
10/22
08:19
10/22/18
08:19
Downgrade
Randgold rating change  »

Randgold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$54.57

0.82 (1.53%)

08:18
10/22/18
10/22
08:18
10/22/18
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HALO

Halozyme

$16.37

-1.22 (-6.94%)

08:18
10/22/18
10/22
08:18
10/22/18
08:18
Hot Stocks
Halozyme reports results of data for PEGPH20 combination »

Halozyme presented data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.